Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

259 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent.
Hjardem E, Hetland ML, Østergaard M, Krogh NS, Kvien TK; Danish Database for Biological Therapies in Rheumatology Study Group. Hjardem E, et al. Among authors: hetland ml. Ann Rheum Dis. 2005 Aug;64(8):1220-3. doi: 10.1136/ard.2004.031252. Epub 2005 Jan 7. Ann Rheum Dis. 2005. PMID: 15640272 Free PMC article.
[Progress in rheumatology. The Danish Society of Rheumatology].
Østergaard M, Kjaer M, Manniche C, Nørregaard J, Wiell C, Hetland ML, Andersen LS. Østergaard M, et al. Among authors: hetland ml. Ugeskr Laeger. 2006 Mar 20;168(12):1240. Ugeskr Laeger. 2006. PMID: 16571331 Danish. No abstract available.
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, Pødenphant J, Hansen G, Lindegaard H, de Carvalho A, Østergaard M, Hørslev-Petersen K; CIMESTRA Study Group. Hetland ML, et al. Arthritis Rheum. 2006 May;54(5):1401-9. doi: 10.1002/art.21796. Arthritis Rheum. 2006. PMID: 16645967 Clinical Trial.
No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation.
Døhn UM, Skjødt H, Hetland ML, Vestergaard A, Møller JM, Knudsen LS, Ejbjerg BJ, Thomsen HS, Ostergaard M. Døhn UM, et al. Among authors: hetland ml. Clin Rheumatol. 2007 Nov;26(11):1857-61. doi: 10.1007/s10067-007-0589-y. Epub 2007 Feb 27. Clin Rheumatol. 2007. PMID: 17332974
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?
Hjardem E, Østergaard M, Pødenphant J, Tarp U, Andersen LS, Bing J, Peen E, Lindegaard HM, Ringsdal VS, Rødgaard A, Skøt J, Hansen A, Mogensen HH, Unkerskov J, Hetland ML. Hjardem E, et al. Among authors: hetland ml. Ann Rheum Dis. 2007 Sep;66(9):1184-9. doi: 10.1136/ard.2006.054742. Epub 2007 Mar 27. Ann Rheum Dis. 2007. PMID: 17389656 Free PMC article.
Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.
Ostergaard M, Unkerskov J, Linde L, Krogh NS, Ravn T, Ringsdal VS, Petri A, Andersen LS, Tarp U, Hansen A, Hjardem E, Hetland ML. Ostergaard M, et al. Among authors: hetland ml. Scand J Rheumatol. 2007 Mar-Apr;36(2):151-4. doi: 10.1080/03009740601089267. Scand J Rheumatol. 2007. PMID: 17476624 No abstract available.
259 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page